Bios -
Brain Atrophy in Multiple Sclerosis

Rohit Bakshi, MD
Associate Professor of Neurology
Brigham and Women’s Hospital
Harvard Medical School

Rohit Bakshi, MD, FAAN, is an associate professor of neurology at Harvard Medical School, neurologist and neuroimager at Brigham and Women's Hospital, director of clinical MRI/MS imaging at the Partners Multiple Sclerosis Center, and researcher at the Center for Neurological Imaging. A Buffalo native and graduate of Cornell University, he received his MD from the SUNY University at Buffalo. As an Alpha Omega Alpha scholar, he completed a one-year neuroscience research fellowship with Dr. Alan Faden at the University of California, San Francisco. He served a one-year internship at the Massachusetts General Hospital and Harvard Medical School followed by a neurology residency at UCLA, where he performed neuroimaging research with Dr. John Mazziotta. He then completed a one-year MRI/CT neuroimaging fellowship at the Dent Neurologic Institute followed by continuing training in functional imaging and brain mapping, including PET and SPECT.

Dr. Bakshi is board-certified in neurology and certified in MRI-CT by the American Society of Neuroimaging. He previously served on the faculty at the University at Buffalo-SUNY, where he rose to the rank of Associate Professor of Neurology with Tenure and was Residency Program Director. He was the founding director of the Buffalo Neuroimaging Analysis Center (BNAC), neurologist and neuroimager, and multiple sclerosis specialist at the Dent Neurologic Institute, the Jacobs Neurological Institute, and Physicians Imaging Centers. In building his research program at the BNAC, he pursued studies of quantitative MRI in MS, funded by the National Institutes of Health, National Science Foundation, and National MS Society. He received the 1998 William H. Oldendorf Award for neuroimaging research. He is a member of the American Neurological Association, has achieved fellow status in the American Academy of Neurology, and is a grant reviewer for NIH. He serves on the editorial board of The Journal of Neuroimaging and as associate editor of NeuroRx. He is the president of the American Society of Neuroimaging. He has delivered more than 100 invited lectures and has authored more than 300 publications, including print and online articles and abstracts, more than 110 of which are peer reviewed articles. His work has appeared in a variety of journals such as
The New England Journal of Medicine, The Journal of Neuroscience, Neurology, NeuroImage, AJNR: American Journal of Neuroadiology, Annals of Neurology, The Journal of Computer Assisted Tomography, NeuroReport, Multiple Sclerosis, Archives of Neurology, Brain Research, The Journal of Neurology Neurosurgery and Psychiatry, and Medscape.

J. Theodore Phillips, MD, PhD
Multiple Sclerosis Center at Texas Neurology

Dr. Ted Phillips is a graduate of the University of Texas at Austin with special honors in chemistry, and received MD and PhD (Immunology) degrees and Neurology Residency training from the University of Texas Southwestern Medical Center at Dallas. He is director of the Multiple Sclerosis Center at Texas Neurology in Dallas, and serves as a Clinical Associate Professor of Neurology at the University of Texas Southwestern Medical Center and Attending Neurologist at Baylor University Medical Center in Dallas. He is a principal developer of a national registry for MS (MSTRAC), and is a principal investigator in several ongoing clinical treatment trials in MS.

Robert Zivadinov, MD, PhD
Associate Professor of Medicine
State University of New York at Buffalo School of Medicine

Robert Zivadinov, MD, PhD, is an associate professor of medicine at the University of Buffalo, State University of New York (SUNY). He has staff privileges at the Jacobs Neurological Institute, Baird MS Research Center, Kaleida Health, Buffalo Neuroimaging Analysis Center and Physician Imaging Center.

Dr. Zivadinov received his MD from the University of Rijeka in Croatia, and he obtained the MS in neurology at the University of Rijeka. He served a one-year internship at the department of neurology at the University of Trieste in Italy, followed by a neurology residency at the same institute in 1995-1999, where he performed neuroimaging research with Professor Marino Zorzon. Under the supervision of Professor Giuseppe Cazzato, he performed training in multiple sclerosis care at Center for Diagnosis and Treatment of Multiple Sclerosis in the department of clinical medicine and neurology at the University of Trieste. In 1999 he became the chief researcher on multiple sclerosis in the same institute. In 1998 he founded the Postimaging Analysis Center at Center for Diagnosis and Treatment of multiple sclerosis, in the department of clinical medicine and neurology at University of Trieste; he covered a role of its executive director from 1998 to 2002.

As a chief researcher, Dr. Zivadinov conducted and led significant and progressive research studies in the field of multiple sclerosis. Since 1999, he has also been a multiple sclerosis research consultant for several international pharmaceutical companies and foundations. Dr. Zivadinov has acquired extensive research experience in multiple sclerosis. His accomplishments in his field include: numerous awards from European and national neurological societies for his published articles, research studies and Research Fellowships.

Dr. Zivadinov obtained his PhD in neurology at the University of Rijeka. In 2003, he was appointed to associate professor of neurology at the University of Buffalo, State University of New York (SUNY) and to director of Buffalo Neuroimaging Analysis Center.

He has authored more than 40 publications, including print and online articles and 85 abstracts. His work has appeared in journals such as
Neurology; The Journal of Neurology, Neurosurgery and Psychiatry; Neuroimage; The Journal of Neurology; Multiple Sclerosis; and Neuroepidemiology .

Dr. Zivadinov is currently pursuing research studies of quantitative MRI findings in multiple sclerosis, therapeutic interventions including strategies towards assessing neuroprotective efforts in multiple sclerosis, but his current interests are also concentrated on genetic and neuroepidemiology fields of the same disease.